By Admin at 23 Mar 2016
GRAIL, an aptly named startup company launched by biotech company Illumina (the same company that has made DNA sequencing affordable and efficient) is setting out to achieve one of the Holy Grails that cancer doctors and researchers have been looking for – a blood test that could detect all cancers.
58
Current Gateway-funded clinical trials
150+
Clinical trials funded at leading institutions worldwide
$16.56
Funds one patient for one day at a Gateway-funded clinical trial